Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126079832 | 12607983 | 2 | F | 2008 | 20160907 | 20160729 | 20160913 | EXP | PHJP2016JP021572 | NOVARTIS | MIYAI T, TSUKAHARA K. A CASE OF A PATIENT WITH NEPHROTIC SYNDROME WHO RESISTED TRANSITION MEDICINE AT THE DEPARTMENT OF INTERNAL MEDICINE DUE TO A POSITIVE RELATIONSHIP WITH THE PRIMARY CARE PHYSICIAN. JAPANESE JOURNAL OF PEDIATRIC NEPHROLOGY/ THE 51ST ANNUAL MEETING OF THE JAPANES. 2016;29:142 | 0.00 | A | F | Y | 34.90000 | KG | 20160913 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126079832 | 12607983 | 1 | PS | NEORAL | CYCLOSPORINE | 1 | Oral | UNK | Y | 0 | CAPSULE | ||||||||
| 126079832 | 12607983 | 2 | SS | NEORAL | CYCLOSPORINE | 1 | Oral | 120 MG, QD | Y | 0 | 120 | MG | CAPSULE | QD | |||||
| 126079832 | 12607983 | 3 | SS | NEORAL | CYCLOSPORINE | 1 | Oral | 200 MG, QD | Y | 0 | 200 | MG | CAPSULE | QD | |||||
| 126079832 | 12607983 | 4 | SS | NEORAL | CYCLOSPORINE | 1 | Oral | 220 MG, QD | Y | 0 | 220 | MG | CAPSULE | QD | |||||
| 126079832 | 12607983 | 5 | SS | NEORAL | CYCLOSPORINE | 1 | Oral | 200 MG, QD | Y | 0 | 200 | MG | CAPSULE | QD | |||||
| 126079832 | 12607983 | 6 | SS | NEORAL | CYCLOSPORINE | 1 | Oral | 180 MG, QD | Y | 0 | 180 | MG | CAPSULE | QD | |||||
| 126079832 | 12607983 | 7 | SS | NEORAL | CYCLOSPORINE | 1 | Oral | 150 MG, QD | Y | 0 | 150 | MG | CAPSULE | QD | |||||
| 126079832 | 12607983 | 8 | SS | NEORAL | CYCLOSPORINE | 1 | Oral | 100 MG, QD | Y | 0 | 100 | MG | CAPSULE | QD | |||||
| 126079832 | 12607983 | 9 | SS | NEORAL | CYCLOSPORINE | 1 | Oral | UNK (DOSE REDUCTION) | Y | 0 | CAPSULE | ||||||||
| 126079832 | 12607983 | 10 | SS | NEORAL | CYCLOSPORINE | 1 | Oral | 50 MG, QD | Y | 0 | 50 | MG | CAPSULE | QD | |||||
| 126079832 | 12607983 | 11 | C | PREDONINE | PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 126079832 | 12607983 | 12 | C | SELBEX | TEPRENONE | 1 | Oral | 50 MG, TID | 0 | 50 | MG | CAPSULE | TID | ||||||
| 126079832 | 12607983 | 13 | C | ISODINE | POVIDONE-IODINE | 1 | Oropharingeal | UNK | 0 | MOUTHWASH | |||||||||
| 126079832 | 12607983 | 14 | C | RENIVACE | ENALAPRIL | 1 | Oral | 5 MG, QD | 0 | 5 | MG | TABLET | QD | ||||||
| 126079832 | 12607983 | 15 | C | BREDININ | MIZORIBINE | 1 | Oral | 350 MG, QD | Y | 0 | 350 | MG | TABLET | QD | |||||
| 126079832 | 12607983 | 16 | C | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Oral | 750 MG, BID | 0 | 750 | MG | CAPSULE | BID | ||||||
| 126079832 | 12607983 | 17 | C | BONALON | ALENDRONATE SODIUM | 1 | Oral | 35 MG, QW | 0 | 35 | MG | TABLET | /wk | ||||||
| 126079832 | 12607983 | 18 | C | ALFAROL | ALFACALCIDOL | 1 | Oral | 0.5 UG, UNK | 0 | .5 | UG | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126079832 | 12607983 | 1 | Nephrotic syndrome |
| 126079832 | 12607983 | 11 | Nephrotic syndrome |
| 126079832 | 12607983 | 12 | Prophylaxis |
| 126079832 | 12607983 | 13 | Prophylaxis |
| 126079832 | 12607983 | 14 | Hypertension |
| 126079832 | 12607983 | 15 | Nephrotic syndrome |
| 126079832 | 12607983 | 16 | Nephrotic syndrome |
| 126079832 | 12607983 | 17 | Osteoporosis |
| 126079832 | 12607983 | 18 | Osteoporosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126079832 | 12607983 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126079832 | 12607983 | Blood creatinine increased | |
| 126079832 | 12607983 | Nephropathy toxic | |
| 126079832 | 12607983 | Nephrotic syndrome | |
| 126079832 | 12607983 | Renal impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126079832 | 12607983 | 1 | 199610 | 0 | ||
| 126079832 | 12607983 | 2 | 200701 | 200712 | 0 | |
| 126079832 | 12607983 | 3 | 200712 | 0 | ||
| 126079832 | 12607983 | 4 | 20090615 | 20091130 | 0 | |
| 126079832 | 12607983 | 5 | 20091201 | 20100628 | 0 | |
| 126079832 | 12607983 | 6 | 20100629 | 20101108 | 0 | |
| 126079832 | 12607983 | 7 | 20101109 | 20121224 | 0 | |
| 126079832 | 12607983 | 8 | 20121225 | 0 | ||
| 126079832 | 12607983 | 9 | 20140324 | 0 | ||
| 126079832 | 12607983 | 10 | 20151215 | 0 | ||
| 126079832 | 12607983 | 11 | 199601 | 0 | ||
| 126079832 | 12607983 | 13 | 199601 | 0 | ||
| 126079832 | 12607983 | 14 | 20061121 | 0 | ||
| 126079832 | 12607983 | 15 | 20080331 | 20091215 | 0 | |
| 126079832 | 12607983 | 16 | 20091215 | 0 | ||
| 126079832 | 12607983 | 17 | 20090210 | 0 | ||
| 126079832 | 12607983 | 18 | 20090210 | 0 |